ADT Sets Special Meeting to Vote on $10.00 Cash Thrive Buyout
ADT sits 64% above its 52-week low of $6.03.
Summary
ADT filed the preliminary proxy for its $10.00-per-share all-cash sale to Thrive Holdings, setting a 2027 special meeting and detailing the $227 million break fee, $473 million reverse fee, fully committed financing and HSR timing. The board unanimously recommends the deal.
Key Events · M&A and Partnerships · ADT
-
Special Meeting Set for $10.00 Cash Merger
Stockholders will vote on adopting the October 29, 2026 merger agreement with Thrive Holdings' Abode Parent at $10.00 per share in cash; the board unanimously recommends FOR.
-
Majority-of-Outstanding Vote Required
Approval needs a majority of all outstanding shares, so abstentions and failures to vote count as votes against; directors and officers hold 30,465,266 shares, about 4.17%.
-
Break Fees and Go-Shop Terms
Company termination fee is $227,000,000, cut to $114,000,000 for a superior proposal signed during the go-shop ending November 28, 2026; Parent pays $473,000,000 if it walks, backed by a Thrive guarantee capped at $481,000,000.
-
Financing Fully Committed, No Condition
Thrive committed $4,895,000,000 of equity, Apollo and Atlas committed $9,727,500,000 of debt and Apollo affiliates up to $1,625,000,000 of preferred equity; closing is not conditioned on financing.
Analysis · ADT · Trade & Services
This is the formal proxy for the $10.00-per-share all-cash sale to Thrive Holdings, and it puts hard numbers and dates on a deal the market only knew in outline. The board unanimously recommends approval, and the vote is the gating item: a majority of all outstanding shares must vote yes, so a low turnout effectively counts as a no. The proxy also lays out the escape hatches and the money behind the deal — a $227 million break fee ($114 million if a superior proposal emerges during the go-shop that ends November 28, 2026), a $473 million reverse fee guaranteed by Thrive, and $4.895 billion of committed Thrive equity plus $9.7 billion of Apollo/Atlas debt, with no financing condition. HSR review is the other clock: filings went in November 13, 2026 and the waiting period is set to expire December 14, 2026, with a July 29, 2027 outside date. The disclosed 2027 forecast of $5.544 billion revenue and $2.723 billion Adjusted EBITDA is the number holders will weigh against $10.00 in cash.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ADT was trading at $9.88 on NYSE in the Trade & Services sector, with a market capitalization of approximately $6.7B. The 52-week trading range was $6.03 to $10.00. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.